You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Harvard Business School
Merck
Mallinckrodt
McKinsey

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Patent: 5,011,678

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,011,678
Title: Composition and method for administration of pharmaceutically active substances
Abstract:Pharmaceutically active substances are administered in aerosol form by applying to a mucosal surface of the body a composition comprising a medically effective amount of a pharmaceutically active substance, a biocompatible amphiphilac steroid and a bicompatible (hydro/fluoro)carbon propellant.
Inventor(s): Wang; Yu-chang J. (Los Altos, CA), Lee; William A. (Los Altos, CA), Narog; Blair (Palo Alto, CA)
Assignee: California Biotechnology Inc. (Mountain View, CA)
Application Number:07/305,520
Patent Claims:see list of patent claims

Details for Patent 5,011,678

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Baxter Hlthcare Corp MYXREDLIN insulin human SOLUTION;INTRAVENOUS 208157 001 2019-06-20   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX Orphan search
Lilly HUMULIN R PEN insulin recombinant human INJECTABLE;INJECTION 018780 005 1982-12-02   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX search
Lilly HUMULIN R insulin human SOLUTION;SUBCUTANEOUS 018780 004 1982-12-02   Start Trial California Biotechnology Inc. (Mountain View, CA) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKinsey
Johnson and Johnson
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.